Anavex Life Sciences Corp (AVXL)

[Hoskuld]

I don't think competing with mabs is much of a competition: 2-73 is more efficacious and safer and doesn't require the high overhead of drug administration on top of the price of the drugs and doesn't require MRIs every few weeks. When you take the mabs your brain shrinks...faster! Not a selling point.

Either way, with a partner or without a partner, 2-73 is going to go head to head with mabs.

Hopefully we get a partner or get bought out.